Abstract
Background During cardiopulmonary bypass (CPB), maintaining adequate oxygen consumption (VO2i) can only be achieved indirectly either by modifying oxygen delivery (DO2i) through its component parts or by modulating metabolic demand through altering body temperature. The body reacts to these actions by changing OER and consequently VO2i. Understanding the body’s adaptive OER dynamics can elucidate its oxygen consumption goals during CPB and help improve our ability to safely manage the patient’s journey.
Methods An autoregressive, integrated time-series model was trained on granular perfusion data from 879 paediatric patients (age: newborn to 18 years old) undergoing 963 CPB operations, with the outcome variable being the minute-by-minute changes in the logit transformation of OER. Variables were cardiac index, haemoglobin concentration, oxygen saturation of arterial haemoglobin and temperature. An explicit ‘disequilibrium term group’ was also included, proportional to the difference between the logarithm of VO2i and logarithm of a ‘latent’ (i.e. unobserved) oxygen demand - or ‘target’ VO2 (tVO2i) - term, with the logarithm of tVO2i assumed to be a linear function of body temperature (the Van’t Hoff model). The trained time-series models were studied using permutation-based variable importance, deterministic and stochastic simulations, and subgroup analysis by acute kidney injury (AKI) grade and by temperature.
Results Model coefficients are consistent with an adaptive OER response to keep VO2i in line with tVO2i, according to body temperature. This adaptation consists of a primary rapid response for 5-10 minutes, and a secondary slow response that is estimated to last up to several hours. The model reproduces the hyperbolic shape of DO2i-VO2i curves - first published in 1982 - as an artefact of insufficient wait times between equilibrium-state transitions. Asymptotically, however, the model converges to a piecewise linear relationship between DO2i and VO2i, with supply-independence of oxygen consumption occurring above a threshold DO2i. Subgroup analysis by temperature suggests that the dependence of tVO2i on temperature (expressed as Q10) may be significantly stronger at low temperatures (< 28C) than at high temperatures (> 28C).
Conclusions This study proposes a physiologically plausible model of OER changes during CPB that is consistent with past experimental data. While during CPB, under-oxygenation is the dominant risk in the long term, slow adaptation of OER during CPB creates short-term opportunities for over-oxygenation following significant changes in variables such as cardiac index. The model provides well-defined values for tVO2i at a given temperature, paving the way for further research into the effects of over- and under-oxygenation during CPB on postoperative outcomes such as AKI, and hence improvements in goal-directed perfusion protocols.
What Is New?
This study is the first to present a data-driven, analytical framework for predicting OER changes in response to clinical interventions during CPB.
Changes in the components of oxygen delivery cause an adaptive OER response to keep oxygen consumption in line with oxygen demand, according to body temperature.
The dependence of oxygen demand on temperature decreases as temperature increases towards normothermia, inconsistent with the accepted Van’t Hoff equation.
Children developing AKI exhibit a dampened response to changes in haemoglobin during CPB, with this dampening of response intensifying with AKI severity.
What Are the Clinical Implications?
This proposed, dynamic model of OER provides a novel framework for goal-directed perfusion by identifying periods of over- and under-oxygenation.
The observed, dampened response to haemoglobin changes in patients that develop AKI can be the foundation of an intraoperative tool for early diagnosis of at-risk patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Great Ormond Street Hospital for Children, London gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Nonstandard Abbreviations and Acronyms
- AKI
- acute kidney injury
- GARIX
- global autoregressive Integrated (time-series model) with exogenous variables
- GARIX+
- GARIX model, plus a disequilibrium term group (in addition to autoregressive and exogenous term groups)
- ATG
- autoregressive term group
- BSA
- body surface area (m2)
- CI
- cardiac index (blood flow indexed BSA) (L/min/m2)
- CPB
- cardiopulmonary bypass
- CV
- cross-validation
- DHCA
- deep hypothermic circulatory arrest
- DO2
- oxygen delivery (mL/min)
- DO2i
- oxygen delivery, indexed to BSA (mL/min/m2)
- DTG
- disequilibrium term group
- EHR
- electronic health record
- ETG
- exogenous term group
- GDP
- goal-directed perfusion
- Hb
- haemoglobin content of blood (g/dL)
- HLM
- heart-lung machine
- i.i.d.
- Independent and identically distributed
- ML
- machine learning
- OER
- oxygen extraction ratio
- OG
- oxygenation gGap
- OOS
- out-of-sample
- PaO2
- partial pressure of oxygen (kPa)
- PVI
- permutation-based variable importance
- Q10
- multiplicative increase in the resting metabolic rate for every 10°C increase in body temperature
- RBCs
- red blood cells
- RMR
- resting metabolic rate
- RTO
- return-to-equilibrium (an estimated parameter in the GARIX+ model)
- SaO2
- oxygen saturation of arterial blood (scale: 0-100)
- SvO2
- Oxygen saturation of mixed venous blood (scale: 0-100)
- TG
- term group
- tVO2i
- target (indexed) oxygen consumption, aka (indexed) oxygen demand (mL/min/m2)
- tDO2i
- threshold (indexed) oxygen delivery (mL/min/m2)
- VI
- variable importance
- VO2
- oxygen consumption (mL/min)
- VO2i
- oxygen consumption, indexed to BSA (mL/min/m2)